Mitral Regurgitation Articles & Analysis
4 articles found
Study Overview: Design: Prospective, randomized, open-label, multi-center, international, clinical safety and efficacy investigation. Randomization: Treatment with AccuCinch System plus guideline-directed medical therapy (GDMT) or GDMT alone. Enrollment: 400 randomized subjects at up to 80 centers worldwide ...
“With the V-LAP, physicians have remote access to left atrial pressure — potentially informative and effective data for treating heart failure patients, especially the ones with concomitant pulmonary hypertension and/or mitral regurgitation. Remote monitoring of LAP has a great potential to keep those patients well and out of the ...
The multicenter, nonrandomized, prospective study is assessing the system in patients with symptomatic heart failure and concomitant functional mitral regurgitation (FMR) who have stable symptoms on guideline-directed medical therapy. ...
The latest available analysis of the first 31 heart failure patients with functional mitral regurgitation treated with the AccuCinch system at leading heart centers across the United States was presented by Satya Shreenivas, M.D., interventional cardiologist at The Christ Hospital Heart and Vascular Center and The Carl and Edyth Lindner Center for Research and ...